Literature DB >> 30560368

[Management of osseous complications in multiple myeloma].

K Zarghooni1, S Hopf2, P Eysel2.   

Abstract

Skeletal lesions caused by multiple myeloma often lead to pain, pathological fractures, spinal instability, and compression of the spinal cord and nerve roots. The choice of therapy options is made by an interdisciplinary basis with oncologists and radiotherapists on the basis of comorbidities, prognosis, localization, and number of lesions. Surgical management has a supportive role in pain relief, the prevention and treatment of pathological fractures, and the decompression of the spinal cord and nerve roots. An adequate preoperative workup is essential for planning surgical treatment, which includes magnetic resonance imaging of the spine. In the case of unstable spinal lesions, minimally invasive and open surgical procedures, as well as their combination, are available for stabilization and decompression. In impending and pathological fractures of the extremities, surgical procedures are superior to conservative therapy for pain relief, restoring stability, walking ability, and limb function. There are multiple options available, including osteosynthesis using bone cement and plates, intramedullary nails, and bone replacement with implants and tumor endoprostheses with good functional results. Permanent reconstruction of the lesions should be the goal of any surgical intervention. The indication for curative, wide resection of the tumor should be considered for solitary plasmocytomas of the bone. Adjuvant radiotherapy leads to significantly improved local tumor control and should be considered after resection and stabilization.

Entities:  

Keywords:  Endoprostheses; Metastasis, spinal; Plasmacytoma; Radiotherapy, adjuvant; Surgical oncology

Mesh:

Year:  2019        PMID: 30560368     DOI: 10.1007/s00108-018-0530-2

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  29 in total

Review 1.  Multiple myeloma of the spine.

Authors:  Arian Lasocki; Frank Gaillard; Simon J Harrison
Journal:  Neuroradiol J       Date:  2017-04-20

Review 2.  The Diagnosis and Treatment of Multiple Myeloma.

Authors:  Christian Gerecke; Stephan Fuhrmann; Susanne Strifler; Martin Schmidt-Hieber; Hermann Einsele; Stefan Knop
Journal:  Dtsch Arztebl Int       Date:  2016-07-11       Impact factor: 5.594

3.  Long-term survival after surgical intervention for bone disease in multiple myeloma.

Authors:  F Zeifang; A Zahlten-Hinguranage; H Goldschmidt; F Cremer; L Bernd; D Sabo
Journal:  Ann Oncol       Date:  2005-02       Impact factor: 32.976

Review 4.  The treatment of spinal metastases.

Authors:  Karl-Stefan Delank; Clemens Wendtner; Hans Theodor Eich; Peer Eysel
Journal:  Dtsch Arztebl Int       Date:  2011-02-04       Impact factor: 5.594

Review 5.  Management of bone disease in multiple myeloma.

Authors:  Evangelos Terpos; James Berenson; Noopur Raje; G David Roodman
Journal:  Expert Rev Hematol       Date:  2014-01-16       Impact factor: 2.929

Review 6.  State of the Art Treatment of Spinal Metastatic Disease.

Authors:  Ori Barzilai; Charles G Fisher; Mark H Bilsky
Journal:  Neurosurgery       Date:  2018-06-01       Impact factor: 4.654

7.  Review of 1027 patients with newly diagnosed multiple myeloma.

Authors:  Robert A Kyle; Morie A Gertz; Thomas E Witzig; John A Lust; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew E Plevak; Terry M Therneau; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2003-01       Impact factor: 7.616

8.  Assessment of the risk factors for impending fractures following radiotherapy for long bone metastases using CT scan-based virtual simulation: a retrospective study.

Authors:  Zuzana Tatar; Martin Soubrier; Anne Françoise Dillies; Pierre Verrelle; Stéphane Boisgard; Michel Lapeyre
Journal:  Radiat Oncol       Date:  2014-10-16       Impact factor: 3.481

9.  Oncological and functional results of the surgical treatment of vertebral metastases in patients with multiple myeloma".

Authors:  Grzegorz Guzik
Journal:  BMC Surg       Date:  2017-08-23       Impact factor: 2.102

Review 10.  Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert Panel.

Authors:  J Caers; B Paiva; E Zamagni; X Leleu; J Bladé; S Y Kristinsson; C Touzeau; N Abildgaard; E Terpos; R Heusschen; E Ocio; M Delforge; O Sezer; M Beksac; H Ludwig; G Merlini; P Moreau; S Zweegman; M Engelhardt; L Rosiñol
Journal:  J Hematol Oncol       Date:  2018-01-16       Impact factor: 17.388

View more
  2 in total

1.  Multiple myeloma characterized by synovial fibrinoid necrosis: a case report.

Authors:  You Jun Liu; Fan Mei Ge
Journal:  J Int Med Res       Date:  2021-01       Impact factor: 1.671

2.  Bioinformatics Analysis of the Key Genes and Pathways in Multiple Myeloma.

Authors:  Xinge Sheng; Shuo Wang; Meijiao Huang; Kaiwen Fan; Jiaqi Wang; Quanyi Lu
Journal:  Int J Gen Med       Date:  2022-09-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.